CVS Health CEO; “10,000 staffers are ready to vaccinate” & Starbucks’ 2021 Rebound
The Food and Drug Administration votes today on whether to recommend the approval of Pfizer and BioNTech’s coronavirus vaccine for emergency use. CVS Health Chief Executive Larry Merlo said the company is ready to administer “vaccines into the arms of some of our most vulnerable populations” within 24 to 48 hours upon receiving its share of Covid-19 vaccines. Starbucks lost billions of dollars in sales this year due to the coronavirus pandemic, but sales in the United States and China have been rebounding faster than expected. Starbucks CEO Kevin Johnson discussed the company’s projections for 2021 as hopes rise over a coronavirus vaccine becoming available to the general public. Plus, consumers’ holiday spending plans in data from CNBC’s All America Economic Survey.
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
The Food and Drug Administration votes today on whether to recommend the approval of Pfizer and BioNTech’s coronavirus vaccine for emergency use. CVS Health Chief Executive Larry Merlo said the company is ready to administer “vaccines into the arms of some of our most vulnerable populations” within 24 to 48 hours upon receiving its share of Covid-19 vaccines. Starbucks lost billions of dollars in sales this year due to the coronavirus pandemic, but sales in the United States and China have been rebounding faster than expected. Starbucks CEO Kevin Johnson discussed the company’s projections for 2021 as hopes rise over a coronavirus vaccine becoming available to the general public. Plus, consumers’ holiday spending plans in data from CNBC’s All America Economic Survey.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.